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INTRODUCTION
In the Netherlands approximately 600 000 patients
are known to have type 2 diabetes.1 Of these
patients, 75% are primarily being treated in general
practice.2 It has been emphasised that case mixes in
primary and in secondary care are unequal, and that
it is necessary to take these inequalities into account
when comparing the outcome of care in different
settings.3,4 In general, there is as much variation in
outcomes within disciplines as between them.5
Diabetes care is shared care and, consequently,
close cooperation between hospitals and GPs is
essential. Given the necessity to collaborate,
knowledge about what is achievable both in and
outside the hospital is important, as this will
influence the development and implementation of
guidelines and the sharing of responsibilities. There
is a need for an objective method to assess the
quality of diabetes care, both in general practice
and at outpatient clinics.
The Diabetes Quality Improvement Project has
developed a comprehensive set of measures to
assess quality of care accurately and reliably.
Implementation of this set of measures is expected
to bring quality improvement.6 Recently the Quality
of Care and Outcomes in Type 2 Diabetes study
group developed a quality-of-care summary score
ABSTRACT
Background
In diabetes care, knowledge about what is achievable in
primary and secondary care is important. There is a need
for an objective method to assess the quality of care in
different settings. A quality-of-care summary score has
been developed based on process and outcome
measures. An adapted version of this score was used to
evaluate diabetes management in different settings.
Aim
To evaluate the quality of diabetes management in
primary and secondary care in a defined geographic




Thirty general practices in the Netherlands.
Method
A study of 2042 patients with type 2 diabetes (1640
primary care and 402 secondary care) was conducted.
Quality of diabetes management was assessed by a
score of process and outcome indicators (range 0–40).
Clustering at practice level and differences in patient
characteristics (case mix) were taken into account.
Results
At the outpatient clinic, patients were younger (mean age
64.1 years, standard deviation (SD) = 12.5 years, versus
mean age 67.1 years, SD = 11.7, P<0.001), had more
diabetes-related complications (macrovascular: 39.7%
versus 24.3%, P<0.001; and microvascular: 25.9%
versus 7.3%, P<0.001), and lower quality-of-life scores
(EuroQol-5D: mean = 0.60, SD = 0.29, versus mean =
0.80, SD = 0.21, P<0.001). After adjusting for case mix
and clustering, there was a weak association between the
setting of treatment and haemoglobin A1c (primary care:
mean 7.1%, SD = 1.1, versus secondary care: mean
7.6%, SD = 1.2, P<0.016), and between setting and
systolic blood pressure (primary: mean 145.7 mmHg, SD
= 19.2, versus secondary care: 147.77 mmHg, SD 21.0,
P<0.035). Quality-of-care summary scores in primary and
secondary care differed significantly, with a higher score in
primary care (mean 19.6, SD = 8.5 versus, mean 18.1, SD
= 8.7, P<0.01). However, after adjusting for case mix and
clustering, this difference lost significance.
Conclusion
GPs and internists are treating different categories of
patients with type 2 diabetes. However, overall quality of
diabetes management in primary and secondary care is
equal. There is much room for improvement. Future
guidelines may differentiate between different categories
of patients.
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(QuED) based on readily available process and
intermediate outcome indicators.7 Only indicators
with a strong link with vascular complications were
used. These measures were consistent with those
adopted for the Diabetes Quality Improvement
Project. After adjusting for case mix and clustering,
a linear relationship between quality score and the
incidence of cardiovascular events was found.
Similar scores have not been used previously to
evaluate the quality of diabetes management in a
primary and secondary care setting simultaneously.
The current study aims to fill this gap.
METHOD
In the Netherlands, everyone is registered with a
general practice. All diabetes-related expenses are
reimbursed by insurance companies. By law, all
inhabitants are insured by one of these companies
and when needed, subsidiaries are given to pay for
insurance costs. A cluster randomised trial was
performed comparing usual care with care
according to locally-adapted shared care guidelines
near Apeldoorn, a city with 150 000 inhabitants.
This paper describes the cross-sectional evaluation
of diabetes management in primary and secondary
care at the start of the intervention.
Participants
All primary care practices (n = 70) in the region, and
all internists (n = 9) at the local hospital were asked
to participate. All patients with diabetes (n = 3357)
on the lists of the participating practices were
eligible for this project, both those cared for by a
GP and those treated at the outpatient clinic. In
general practice, a computer search was performed
to identify all patients known to have type 2
diabetes. Reasons for exclusion were the inability to
complete a questionnaire, severe mental illness,
unwillingness to attend the practice regularly, and a
limited life expectancy.
Measures
General practice. At baseline, demographics,
duration of diabetes, smoking habits, comorbidity,
and the presence of macrovascular or
microvascular complications were recorded.
Standardised operating procedures were used to
record body weight, height, and blood pressure.
Fasting blood and urine samples were analysed at
the local hospital laboratory. Haemoglobin A1c
(HbA1c) was determined by the Variant II™ Turbo
Haemoglobin Testing System (Bio-Rad). Plasma
glucose, total cholesterol, high-density lipoprotein
cholesterol, triglycerides, albumin/creatinine ratio,
and microalbumen were determined with Architect®
ci8200SR (Abbott).
Outpatient clinic. Specially trained nurses examined
the records of all participants, extracted
anthropometric data, and checked the histories of
these patients for duration of diabetes, smoking
habits, comorbidity, and the presence of
macrovascular or microvascular complications. The
records of the hospital laboratory were used to
obtain the results of biochemical tests performed
during the year preceding the start of the study.
Both settings. Health-related quality of life was
estimated with the EuroQol-5D (range –0.59 to –1,
where 1 indicates perfect health) and the validated
Dutch version of the disease-specific Diabetes
Health Profile (range 0–100, where 100 represents
no dysfunction).8,9 The overall health of the
participants and their treatment satisfaction were
measured with the visual analogue scale of the
EuroQol-5D (range 0–100), and the treatment
satisfaction questionnaire (range 0–36)
respectively.10,11
The files of all 18 pharmacists and those of three
GPs who had their own pharmacy were used to
obtain a detailed medication profile of all patients
using blood glucose lowering medication
(Anatomical Therapeutic Chemical Classification
System code A10), or those who had been
diagnosed with diabetes by their GP. Subsequently,
these profiles were matched with the research data.
Yearly measurement of HbA1c, blood pressure,
total cholesterol, albumin/creatinine ratio, and the
prescription of angiotensin II (ATII) antagonists or
angiotensin-converting enzyme (ACE) inhibitors in
cases of microalbuminuria were identified as
measures of the process of care. The percentages
of patients with HbA1c <8%, systolic blood
pressure <140 mmHg, diastolic blood pressure
<8 mmHg, mean cholesterol <6 mmol/l for non-
smokers or <5 mmol/l for smokers, and diabetes
treatment satisfaction were used as outcome
measures.
Because local shared care guidelines differed
How this fits in
There has been much debate about the quality of primary diabetes care.
Generally, the process of care tends to be better in a secondary care setting,
but differences in metabolic outcome between the primary and secondary care
setting are less clear. When using a multi-item quality score consisting of
process and outcome measures, the overall quality of diabetes care was equal
after correcting for the different distributions of patient characteristics (case mix)
as they occur in different health care settings. GPs and internists are treating
different categories of patients with type 2 diabetes. As total quality scores were
low, there is room for improvement.
Original Papers
from those used by the Italian Quality of Care and
Outcomes in Type 2 Diabetes study group,3 slight
modifications had to be made to the original quality
summary score. The threshold for diastolic
hypertension was set at 85 mmHg instead of
90 mmHg. Total cholesterol was used as a
substitute for low-density lipoprotein cholesterol.
Instead of ACE inhibitors only, both ACE inhibitors
and ATII antagonists were recommended in cases
of microalbuminuria. The quality score was, like the
original Italian score, designed prior to the data
analysis and was not based on weights derived
from regression models. The lowest score was
assigned if a patient was not effectively treated
despite elevated values. An intermediate score was
credited if treatment goals were met, but
measurement of a parameter was not performed
within the last 12 months. Finally, the highest score
was given if patients were treated in line with both
process and outcome indicators (Table 1).
Analysis
The term ‘case mix’ is used to describe the
distribution of patient characteristics in different
healthcare settings. These characteristics are
hypothesised to remain the same if a patient is
assigned to another unit of care.12 As the
distribution of such characteristics is not random, it
may lead to case-mix bias.4 In this study, sex, age,
duration of diabetes, macrovascular and
microvascular complications, education, insulin
use, and quality of life are considered case-mix
variables. In the Quality of Care and Outcomes in
Type 2 Diabetes study, the risk of developing a
cardiovascular event was 89% greater in patients
with a score of ≤10, and 43% higher in those with a
score between 10–20, as compared to those with a
score >20. The same cut-off points were used in the
present study. To assess differences in baseline
measurements between primary and secondary
care, the Student’s t test, Mann–Whitney test, and
χ² test, were used where appropriate. A threshold
value of at least one measurement per year was
considered to be desirable, whatever the
physicians’ case mix.
Therefore, differences in the process of care
between specialties were not adjusted for potential
confounding by unequal case mixes. In the case of
outcome measurements, multiple regression
analysis was performed to account for
confounding by case-mix differences between the
primary and secondary care setting. Because
multiple tests were involved, statistical significance
was set at P<0.01. In both primary and secondary
care, generalised estimating equations models
were used to adjust for clustering at practice level.
Analyses were carried out using the statistical
package SPSS (version 12.0) for Windows. SAS
software (version 8) was used for generalised
estimating equations. Analyses were performed for
both summary scores: the original QuED score,
and the adapted version.
The percentage of missing values per variable
ranged between 0% and 25.2%; mean 17.6%.
Ignoring cases with a missing value may lead to
biased results and loss of power.13,14 Therefore,
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Quality-of-care indicator Score
HbA1c ≥8.0% 0
HbA1c <8.0% but measurement less than 1 per year 5
HbA1c <8.0% and measurement at least 1 per year 10
Blood pressure >140/85 mmHg 0
Blood pressure values <140/85 mmHg but measurement less than 1 per year 5
Blood pressure values <140/85 mmHg and measurement at least 1 per year 10
Cholesterol ≥5 mmol/l (non-smokers without vascular complications) ≥6 mmol/l 0
Cholesterol <5 mmol/l (non-smokers without vascular complications) <6 mmol/l 5
but measurement less than 1 per year
Cholesterol <5 mmol/l (non-smokers without vascular complications) <6 mmol/l 10
and measurement at least 1 per year
Not treated with ACE inhibitors despite the presence of microalbuminuria 0
Treated with ACE inhibitors or ATII antagonists in the presence of microalbuminuria, 5
or microalbuminuria absent but measurement less than 1 per year
Treated with ACE inhibitors or ATII antagonists in the presence of microalbuminuria, 10
or microalbuminuria absent but measurement at least 1 per year
Score range 0–40
HbA1c = haemoglobin A1c. ACE = angiotensin-converting enzyme. ATII = angiotensin II.
Table 1. Quality of diabetes management scoring system.
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missing values were inputted using the regression
method available in SPSS.
RESULTS
Participants
In total, 11 single-handed, 16 duo, and three group
practices agreed to participate. Reasons for non-
participation were a lack of time, a dislike of
research projects, a lack of confidence in the
outcome of the study, and the conviction that the
practice performed well and did not need
improvement. At the local hospital, all specialists
agreed to participate. Overall, 2042 patients gave
their informed consent. Of these patients, 1640
were treated in primary care, and 402 were cared
for at the outpatient clinic (Figure 1).
Case mix
Patients treated by GPs were older, had a shorter
duration of diabetes, and fewer macrovascular and
microvascular complications. Patients cared for at
the outpatient clinic were more likely to be treated
with insulin and had lower EuroQol-5D, visual
analogue, and Diabetes Health Profile scores
(Table 2).
Process of care
At the outpatient clinic, more patients were annually
checked for their HbA1c, and in cases of
microalbuminuria, more patients were prescribed
an ACE inhibitor or ATII antagonist. Measurement of
microalbuminuria was performed more often in
general practice. After correction for case mix and
clustering, these differences became statistically
non-significant (Table 3).
Outcome of care
HbA1c percentage in secondary care exceeded
that in primary care. In both settings, the
percentage of patients that achieved adequate
blood pressure control was equal. However, more
patients in secondary care attained adequate lipid
3357 patients with 
type 2 diabetes
374 patients excluded because 
of the inability to complete a
questionnaire: (n = 22), severe
mental illness (n = 117), abroad
(n = 20), unwillingness to attend
the practice regularly (n = 64),
nursing home (n = 47), advanced
age (n = 65), or a limited life 













Case mix Primary care Secondary care P-value
Male, % 48.6 46.0 0.4
Age, years (SD) 67.1 (11.7) 64.1 (12.5) <0.001
Primary school and technical school, % 57.9 54.0 0.2
Duration of diabetes, % (SD) 6.6 (6.0) 11.2 (7.7) <0.001
Macrovascular complications, % 34.3 39.7 <0.001
Microvascular complications, % 7.3 25.9 <0.001
Insulin use, % 5.7 65.8 <0.001
EuroQol-5D (SD) 0.80 (0.21) 0.70 (0.29) <0.001
EuroQol-VAS (SD) 75.3 (16.1) 68.3 (18.3) <0.001
Diabetes Health Profile (SD) 84.9 (9.8) 79.5 (11.1) <0.001
Table 2. Case-mix variables in primary and secondary care.
Figure 1. Flow chart of
participation
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control. In general, patients were satisfied with their
treatment. After correction for case mix and
clustering, differences in mean HbA1c percentage
and the percentage of patients with HbA1c <8%
reached borderline significance, and weak evidence
of an association between treatment setting and
systolic blood pressure became apparent (Tables 4
and 5).
Quality score
The overall quality of diabetes care in primary and
secondary care was different. The mean quality-of-
care summary score in general practice was higher
(19.6, standard deviation [SD] = 8.5 versus 18.1, SD
= 8.7 points, difference = 1.41, 95% confidence
interval [CI] = 0.472 to 2.352, P = 0.003), and fewer
patients within primary care had a score ≤10 points
(21.3 versus 26.5%, odds ratio [OR] = 0.74, 95% CI
= 0.573 to 0.946, P = 0.017). However, after
accounting for case mix and clustering, the
difference in quality-of-care score lost significance
(difference = 0.18, 95% CI = –0.247 to 0.612, P =
0.406). Only a weak association between treatment
setting and the percentage of patients with fewer
than 10 points remained (OR = 0.66, 95% CI =
0.465 to 0.949, P = 0.024). A repeated analysis with
the original model by the Quality of Care and
Outcomes in Type 2 Diabetes study group
produced similar results (data not shown).
DISCUSSION
Summary of main findings
At the outpatient clinic, patients were younger, had
more macrovascular and microvascular
343
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Odds ratio (95% CI)
Primary Secondary Full-model
Process care care Unadjusted P-value adjustmenta P-value ICC
HbA1c measurement at least 83.8 90.5 0.55 0.001 0.74 0.416 0.055
1 per year (%) (0.38 to 0.78) (0.36 to 1.52)
Blood pressure measurement at least 56.5 56.4 0.99 0.950 1.10 0.740 0.152
1 per year (%) (0.80 to 1.24) (0.63 to 1.92)
Lipid measurement at least 1 per year (%) 79.7 79.6 1.001 0.992 1.52 0.111 0.086
(0.76 to 1.31) (0.91 to 1.30)
Microalbuminuria measurement at least 45.2 34.7 1.56 <0.001 1.39 0.310 0.186
1 per year (%) (1.24 to 1.95) (0.74 to 2.61)
Prescription of ACE inhibitors or ATII antagonists 52.7 62.3 1.48 0.014 1.24 0.368 0.077
in the presence of microalbuminuria (%) (1.08 to 2.03) (0.77 to 2.01)
aAdjusted for practice-level clustering. HbA1c = haemoglobin A1c. ATII = angiotensin II. ICC = intracluser correlation.
Table 3. Process of care in primary and secondary care.
Difference (95% CI)
Primary Secondary Case-mix Full-model
Outcome care care Unadjusted P-value adjustmenta P-value adjustmentb P-value ICC
HbA1c, % (SD) 7.1 (1.1) 7.6 (1.2) –0.51 <0.001 –0.27 0.001 –0.28 0.016 0.067
(–0.64 to –0.39) (–0.44 to –0.11) (–0.51 to –0.05)
BP systolic, mmHg 145.7 (19.2) 147.7 (21.0) –2.01 0.066 –2.15 0.127 –3.50 0.035 0.024
(–4.15 to 0.13) (–4.90 to –0.60) (–6.75 to –0.25)
BP diastolic, mmHg 82.7 (9.2) 79.6 (11.2) 3.05 <0.001 3.14 <0.001 1.78 0.090 0.044
(2.00 to 4.10) 1.78 to 4.50) (–0.28 to 3.84)
Cholesterol, mmol/l 5.2 (1.0) 5.0 (1.1) 0.21 <0.001 0.14 0.054 0.02 0.827 0.024
(0.10 to 0.32) (–0.002 to 0.28) (–0.19 to 0.24)
Body mass index, kg/m2 29.4 (5.5) 30.2 (6.9) –0.82 0.011 –0.33 0.422 –0.42 0.412 0.009
(–1.45 to –0.19) (–1.12 to 0.47) (–1.41 to o.58)
DTSQ 31.6 (5.2) 30.4 (5.5) 1.23 <0.001 0.03 0.939 –0.19 0.660 0.037
(0.65 to 1.81) (–0.68 to 0.73) (–1.01 to 0.64)
aAdjusted for case-mix differences including sex, age, duration of diabetes, microvascular and macrovascular complications, education, insulin use, and quality
of life. bAdjusted for case-mix differences and practice-level clustering. HbA1c = haemoglobin A1c. BP = blood pressure. DTSQ = Diabetes Treatment
Satisfaction Questionnaire. ICC = intracluser correlation.
Table 4. Outcome of care in primary and secondary care.
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complications, and perceived a lower quality of life.
These case-mix differences are undoubtedly the
result of the Dutch healthcare system, in which
primary care physicians are advised to refer their
patients with type 2 diabetes only for some well-
described indications, usually signs of advanced
disease. Most differences in outcome
measurements between primary and secondary
care became non-significant after adjusting for both
case-mix differences and clustering. However,
mean HbA1c and systolic blood pressure in primary
care remained significantly lower, and more patients
demonstrated an HbA1c <8%.
Limitations of the study
This study has some limitations. Firstly, GPs with a
particular interest in diabetes may have been
selected. However, as approximately half of the
primary care physicians in the study region
participated, and some of them did not even keep a
register of their patients with type 2 diabetes, it can
be assumed those selected were not only those
paying special attention to diabetes care. Secondly,
as the model used by the Quality of Care and
Outcomes in Type 2 Diabetes study group was
adjusted to the local guidelines, its validity to
predict long-term outcomes may have been altered.
Since the modifications made in the present study
gave rise to even stricter targets, the adjusted
model is still able to predict the long-term outcome
of diabetes care. Also, a repeated analysis with the
original model produced similar results.
Thirdly, baseline measurements in primary and
secondary care were performed differently.
Therefore, some differences in treatment outcome
between general practice and outpatient clinic may
be due to differences in data collection. However,
as this study only used the most recent data
available from the patient records in secondary
care, this should not apply. Fourthly, as the present
study has been performed in a defined geographic
region, it is questionable whether the results of this
study can be generalised. The findings of the
present study regarding the quality of diabetes care
in both general practice and outpatient clinic are in
line with those of other studies performed in the
Netherlands.15–18 Consequently, the results of this
study can be considered representative for the
quality of diabetes care in the Netherlands.
Finally, the use of a single imputation procedure
may have resulted in an underestimation of the
standard errors, or P-values that were too small.13
Because it was not possible to demonstrate a
significant difference in the overall quality of
diabetes care between general practice and
outpatient clinic, the results of the present study are
obviously not hampered by the use of a single
imputation procedure.
Comparison with existing literature
The findings of this study are in line with studies
performed in different healthcare settings. In both
the US and in Italy, differences between specialties
became non-significant after adjusting for case-mix
differences and physician-level clustering.3,4 Control
of cardiovascular risk factors in the Italian study
was suboptimal, as 65% of the patients showed
total cholesterol and blood pressure levels above
target.3 These results are in accordance with the
present study, as it also found insufficient blood
pressure control, and cholesterol levels above
target in the majority of participating patients.
A study in 2006 investigating the use of vascular
risk-modifying medications for patients with
diabetes demonstrated remarkable differences
between specialties.19 Patients treated in secondary
care were more likely to receive ACE inhibitors and
ATII antagonists. Differences between study groups
remained after adjusting for case mix and
clustering.19 After taking case mix and physician-
Difference (95% CI)
Primary Secondary Case-mix Full-model
Outcome care care Unadjusted P-value adjustmenta P-value adjustmentb P-value ICC
HbA1c <8%, % 82.9 65.6 0.39 <0.001 0.64 0.009 0.63 0.004 0.037
(0.31 to 0.50) (0.46 to 0.90) (0.46 to 0.87)
BP<140/85 mmHg, % 24.7 25.1 1.03 0.844 1.11 0.551 0.94 0.710 0.011
(0.80 to 1.32) (0.79 to 1.54) (0.70 to 1.27)
Cholesterol <5 mmol/l or 6 mmol/l 41.6 50.5 1.48 <0.001 1.34 0.051 1.21 0.239 0.016
for non-smokers without vascular (1.19 to 1.85) (0.999 to 1.80) (0.88 to 1.67)
complications, %
aAdjusted for case-mix differences including sex, age, duration of diabetes, microvascular and macrovascular complications, education, insulin use, and quality
of life. bAdjusted for case-mix differences and practice-level clustering. HbA1c = haemoglobin A1c. BP = blood pressure. ICC = intracluser correlation.
Table 5. Percentages of patients treated to target.
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level clustering into account, the present study was
unable to reproduce these results.
Implications for future guidelines and
clinical practice
Using a slightly adjusted version of the original
score by the Quality of Care and Outcomes in Type
2 Diabetes study group, this study showed that the
overall quality of diabetes care in a single
geographic region did not differ significantly
between specialties. As patients treated at the
outpatient clinic developed more macrovascular
and microvascular complications despite their
younger age, these patients may have a more
severe course of diabetes. One might argue that
these patients should be treated more aggressively.
In that respect it should be kept in mind that in both
care settings, only one-third of the patients showed
a summary score >20 points, which is related to an
important reduction in cardiovascular events.10
There is still much room for improvement;
treatment should differentiate between patients, not
only regarding the setting of their treatment, but
also regarding the required intensity of disease
management. Future guidelines should take these
facts into consideration. The (adapted) summary
score can be easily managed, and interpretation is
relatively simple. If other studies confirm the results
of the original QuED study, the QuED score could
be recommended on a large scale.
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